A new study warns that a widely used eye ointment can damage a popular glaucoma implant. Researchers found that oil-based ...

Ocular Therapeutix’s lead asset is Axpaxli, being developed for wet age-related macular degeneration. A Phase III study is ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...

USA: A new study, published in Ophthalmology, has revealed that the Pooled Cohort Equations cardiovascular risk score—which ...

While many people in Belfast are aware that obesity can increase the risk of serious health conditions, fewer understand how ...

About 10% of the U.S. population fits into the highest-risk category, with a 20% or higher risk of a cardiac event; 54% are ...

Those with high cardiovascular risk were twice as likely to develop glaucoma and six times as likely to develop AMD as low-risk individuals ...

Study authors at University of California, Los Angeles (UCLA) highlighted that people with higher cardiovascular risk scores ...

Given the success of the previous collection, Prevention and Treatment Advancements in Diabetic Retinopathy, we are pleased to announce the launch of Volume ...

A new study from UCLA Health shows that a cardiovascular risk score already used routinely in primary care can predict who ...

Individuals who are Black or Hispanic are at greater risk of long-term adverse visual outcomes of diabetic retinopathy compared with other groups.

A DEDICATED screening day designed specifically for patients with learning disabilities helped to remove barriers to care and create a “quiet, calm and welcoming” experience for those attending.